-
Dementia with Diabetes Disease Understanding and Treatment Market by DelveInsight
30 Aug 2021 14:52 GMT
… report provides current treatment practices, emerging drugs, and market share … -management and adherence with medication, including the safe administration … for different molecule includes Victoza, Bydureon, Jardiance, Lixisenatide, Sitagliptin, Vildagliptin …
-
FDA OKs Extended-Release Exenatide for Children With T2D
23 Jul 2021 15:24 GMT
… Drug Administration has approved exenatide extended release (Bydureon/Bydureon … recommended as first-line treatment following diet and exercise … is the only oral medication approved for treating pediatric … in ongoing phase 3 trials, including the sodium- …
-
AstraZeneca's T2D Drug BYDUREON BCise Gets Approval In US To Treat Pediatric Patients
23 Jul 2021 14:01 GMT
… its BYDUREON BCise has been approved by the Food and Drug Administration … pediatric patients with T2D.
BYDUREON BCise is the first once … receptor agonist (GLP-1 RA) treatment option for pediatric patients with … EU in 2018 for the treatment of adults with T2D.
…
-
FDA OKs AstraZeneca's BYDUREON BCise in children with type 2 diabetes
23 Jul 2021 13:16 GMT
-
Diabetes Care Drugs Market Size 2021 Global Future Growth, Regional Trend, Leading Players Updates, Industry Demand, Current and Future Plans by Forecast to 2024
26 May 2021 07:02 GMT
…
- Pfizer
- Janssen Pharmaceuticals
- Astellas
- Boehringer … anti-diabetic drugs, non-insulin injectable drugs, and combination drugs), by segment … ● Complications associated with Diabetes Care Drugs procedures. ● For a full … 5.1.3.1.3 Bydureon (Exenatide)
5.1.3 …
-
TRACON Pharmaceuticals Announces Appointment of Dongliang Zhuang, Ph.D. as Vice President of Statistics and Biometrics
03 May 2021 12:05 GMT
… (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ: TCON), a clinical … Bydureon including the pivotal trial that was the basis for FDA … with both Chinese trials sponsored by 3D Medicines. TRACON’s … small molecule drug candidate for the treatment of prostate …
-
Why These Drugs Have Caught the FDA's Eye
09 Nov 2020 21:36 GMT
… professionals through the FDA Adverse Event Reporting … which are diabetes medicines and include Bydureon, Byetta and Saxenda … fibrates in combination with statins, which would increase … medicines without talking with their doctor first. Sometimes, drugs …
-
25 Drugs, Drug Classes Added to FDA's Safety Signal List
22 Oct 2020 01:04 GMT
… Food and Drug Administration (FDA) has added 25 drugs or drug classes … fibric acid derivatives
Drug-induced liver injury
FDA is evaluating the … agonists
Lixisenatide (Adlyxin)
Exenatide (Bydureon)
Exenatide (Bydureon BCise)
Exenatide (Byetta)
Semaglutide …
-
Trulicity, Byetta, Victoza, Similar Diabetes Drugs Do Not Appear to Increase Breast Cancer Risks: Study
26 Mar 2021 02:00 GMT
… medications are part of a widely prescribed class of drugs approved for treatment … Bydureon, Victoza, Saxenda, Adlyxin, Ozempic, Rybelsus and Tanzeum.
Some prior clinical trials … Tags: Breast Cancer, Bydureon, Byetta, Diabetes, Diabetes Drug, Ozempic, Saxenda, …
-
Common drugs for type 2 diabetes and obesity do not increase breast cancer risk
21 Mar 2021 08:30 GMT
… WASHINGTON—Commonly used medications for type 2 … drugs include albiglutide (Tanzeum); dulaglutide (Trulicity); exenatide (Byetta); extended-release exenatide (Bydureon … 52 randomized controlled trials that compared GLP- …
The analysis found treatment with GLP-1 …
About
© 1995-2021